AstraZeneca Lost Money on COVID-19 Vaccine in First Half of 2021

AstraZeneca said losses on Vaxzevria were the main factor that shaved seven percentage points off its Reported Gross Profit Margin, which fell to 73.5 percent in the first half of the year.

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!

July 30, 2021 3 min read

This story originally appeared on The Epoch Times

AstraZeneca, which pledged to provide its COVID-19 vaccine at no profit for the duration of the pandemic, said Thursday that losses in the first half of the year on its vaccine shaved 4 cents off the pharmaceutical giant’s

→ Continue reading at Entrepreneur

More from author

Related posts


Latest posts

Concreit closes on $6M to allow more people to invest in the global private real estate market

Concreit, a company that wants to open real estate investing to a broader group of people, announced today that it has closed $6 million...

New Zealand startup HeartLab raises $2.45M to bring heart scanning software to the US

New Zealand-based medtech startup HeartLab has raised $2.45 million in seed funding that it says will help the company expand its AI-powered heart scanning...

Drowned man identified; second swept from Santa Cruz Coast in three days

Cal Fire and emergency responders from across Santa Cruz County responded for an emergency ocean search Tuesday afternoon at Panther...